Skip to main content

Table 2 Correlation between myocardial glucose uptake and metabolic factors

From: Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes

Variables

r

p

Age (years)

−0.01

0.980

SBP (mmHg)

−0.08

0.145

DBP (mmHg)

−0.02

0.725

BMI (kg/m2)

−0.17

0.002

Visceral fat area (cm2)

−0.26

<0.001

Subcutaneous fat area (cm2)

−0.14

0.025

HbA1c (%)

−0.12

0.027

Glycated albumin (%)

−0.01

0.896

Fasting glucose (mg/dL)

−0.16

0.002

Postprandial glucose (mg/dL)

−0.11

0.066

Fasting insulin (µIU/mL)

−0.13

0.028

Postprandial insulin (µIU/mL)

−0.11

0.069

Fasting C-peptide (ng/mL)

−0.18

0.003

Postprandial C-peptide (ng/mL)

−0.10

0.103

HOMA-IR

−0.15

0.011

TyG

−0.16

0.004

Adipo-IR

−0.32

<0.001

Total cholesterol (mg/dL)

−0.02

0.688

HDL cholesterol (mg/dL)

0.03

0.644

LDL cholesterol (mg/dL)

0.01

0.802

Fasting TG (mg/dL)

−0.16

0.003

Postprandial TG (mg/dL)

−0.23

0.003

Fasting FFA (µEq/L)

−0.33

<0.001

Postprandial FFA (µEq/L)

−0.19

0.020

Lipoprotein(a) (mg/dL)

0.05

0.378

Uric acid (mg/dL)

−0.21

<0.001

  1. Adipo-IR index of adipose tissue insulin resistance, BMI body mass index, DBP diastolic blood pressure, FFA free fatty acids, HOMA-IR Homeostasis model assessment of insulin resistance, HDL high density lipoprotein, LDL low density lipoprotein, SBP systolic blood pressure, TG triglycerides, TyG the product of fasting triglycerides and glucose levels
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840